Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-05
2006-12-05
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S384000, C514S361000, C514S237500, C514S376000, C548S263600, C548S376100, C548S127000, C548S371700, C548S230000, C544S140000
Reexamination Certificate
active
07144911
ABSTRACT:
Novel compounds and methods of using those compounds for the treatment of inflammatory conditions are provided. In a preferred embodiment, modulation of the activation state of p38 kinase protein comprises the step of contacting the kinase protein with the novel compounds.
REFERENCES:
patent: 3818024 (1974-06-01), Krenzer
patent: 4093624 (1978-06-01), Revankar et al.
patent: 4296237 (1981-10-01), Cragoe, Jr.
patent: 4432992 (1984-02-01), Cragoe, Jr. et al.
patent: 5103014 (1992-04-01), Musser et al.
patent: 5494925 (1996-02-01), Court et al.
patent: 6020357 (2000-02-01), Pinto et al.
patent: 6235786 (2001-05-01), Dai et al.
patent: 6294573 (2001-09-01), Curtin et al.
patent: 6319921 (2001-11-01), Cirillo et al.
patent: 6645990 (2003-11-01), Askew et al.
patent: 6916924 (2005-07-01), Tan et al.
patent: 2001/0008898 (2001-07-01), Tomiyama et al.
patent: 2002/0058678 (2002-05-01), Cirillo et al.
patent: 2003/0181411 (2003-09-01), Bosch et al.
patent: 2003/0186221 (2003-10-01), Lockhart et al.
patent: 1115350 (1968-05-01), None
patent: 2156343 (1972-05-01), None
patent: 2341064 (1974-03-01), None
patent: 3406329 (1985-05-01), None
patent: 4302702 (1994-08-01), None
patent: 4337847 (1995-05-01), None
patent: 4343831 (1995-06-01), None
patent: 4414840 (1995-11-01), None
patent: 0021228 (1980-06-01), None
patent: 0021228 (1980-06-01), None
patent: 0025232 (1980-09-01), None
patent: 0025232 (1980-09-01), None
patent: 0031796 (1985-01-01), None
patent: 0031796 (1985-01-01), None
patent: 0031796 (1985-01-01), None
patent: 0739884 (1996-04-01), None
patent: 0739884 (1996-04-01), None
patent: 0867435 (1998-03-01), None
patent: 0867435 (1998-03-01), None
patent: 0956855 (1998-04-01), None
patent: 0956855 (1998-04-01), None
patent: 0927555 (1998-12-01), None
patent: 1281399 (2002-07-01), None
patent: 2337554 (1977-08-01), None
patent: 2396549 (1979-02-01), None
patent: 971307 (1961-03-01), None
patent: 1127875 (1967-03-01), None
patent: 2220206 (1990-01-01), None
patent: WO0214291 (2002-02-01), None
patent: WO0240458 (2002-05-01), None
patent: WO02060876 (2002-08-01), None
patent: WO9119708 (1991-12-01), None
patent: WO 9208693 (1992-05-01), None
patent: WO 9424095 (1994-10-01), None
patent: WO 9515954 (1995-06-01), None
patent: WO 9534540 (1995-12-01), None
patent: WO 9616046 (1996-05-01), None
patent: WO 9619477 (1996-06-01), None
patent: WO 9734900 (1997-09-01), None
patent: WO 9822103 (1998-05-01), None
patent: WO 9915164 (1999-04-01), None
patent: WO 9923093 (1999-05-01), None
patent: WO 9959959 (1999-11-01), None
patent: WO 0002851 (2000-01-01), None
patent: WO 0006550 (2000-02-01), None
patent: WO 0007980 (2000-02-01), None
patent: WO 0018738 (2000-04-01), None
patent: WO0021927 (2000-04-01), None
patent: WO 0041698 (2000-07-01), None
patent: WO 0043384 (2000-07-01), None
patent: WO 0059506 (2000-10-01), None
patent: WO0112621 (2001-02-01), None
patent: WO0114372 (2001-03-01), None
patent: WO 0114372 (2001-03-01), None
patent: WO00174771 (2001-10-01), None
patent: WO0174771 (2001-10-01), None
patent: WO0196298 (2001-12-01), None
patent: WO0214311 (2002-02-01), None
patent: WO0228835 (2002-04-01), None
patent: WO 0204727 (2002-05-01), None
patent: WO 0234727 (2002-05-01), None
patent: WO02060869 (2002-08-01), None
patent: WO03000189 (2003-01-01), None
patent: WO03053368 (2003-07-01), None
patent: WO03059373 (2003-07-01), None
patent: WO03072577 (2003-09-01), None
O'Dell, J., et al., “Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications,” New Engl. J. Med., vol. 334(20), pp. 1287-1291 (May 1996), at p. 1287, col. 1, lines 6-9.
Kern et al., “Synthesis of Macromolecules II. Synthesis of New Diol Oligourethans,” Makromolekulare Chemie, vol. 16, pp. 89-107 (1955).
Investigation of the relationship between the inhibitory activity of glycolic acid oxidase (GAO) and its chemical structure: electron-topological approach; Y. Guzel: Journal of Molecular Structure 366 (1996) 131-137.
Protein kinase inhibitors: emerging pharmacophores 1997-2000; Jacques Dumas; Exp. Opin. Ther. Patent (2001) 11(3); p. 405-429.
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site; Pargellis, Tong, Churchill, Cirillo, Gilmore, Graham, Grob, Hickey, Moss, Pav and John Regan; Nature Structural Biology; vol. 9, No. 4, Apr. 2002; p. 268-272.
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase; Schindler, Bornmann, Pellicena, Miller, Clarkson, Kuriyan; Science Magazine; Sep. 15, 2000; vol. 289; p. 1938-1942.
Synthesis of Novel Uracil-5-Sulphonamide Derivatives of Possible Biological Activity; Nofal, Gadalla, Fathalla and Karnel; Egypt J. Chem. 33; No. 4, p. 375-380 (1990).
The Stereochemistry of Oxidation at Sulfur Oxidation of 2-Thiabicyclo[2.2.1]Heptane; Johnson, Diefenbach, Keiser and Sharp; vol. 25, p. 5649 to 5633; Pergamon Press 1969.
TPAP: Tetra-n-propylammonium Perruthenate, A Mild and Convenient Oxidant for Alcohols; Griffith and Ley; Aldrichimica Acta, vol. 23, No. 1, 1990; pp. 13-19.
Aminolysis and Polymerization of 3-(p-Toluenesulfonoxy) Hydantoin; Zvilichovsky and Zucker; Israel Journal of Chemistry; Vo. 7, 1969, p. 547-554.
Palladium-catalyzed amination of arly halides and sulfonates; Yang and Buchwald; Journal of Organometallic Chemistry 576 (1999) pp 125-146.
A General, Efficient, and Inexpensive Catalyst System for the Coupling of Aryl Iodides and Thiols; Kwong and Buchwald; Organic Letters 2002; vol. 4, No. 20, pp. 3517-3520.
Novel Solution Phase Strategy for the Synthesis of Chemical Libraries Containing Small Organic Molecules; Cheng, Corner, Williams, Myers, and Boger; J. Am. Chem. Soc. 1996, 118, pp. 2567-2573.
A Useful 12-1-5 Triacetoxyperiodiane (the Des-Martin Periodiane) for the Selective Oxidation of Primary or Secondary Alcohols and a Variety of Related 12-1-5 Species; Dess and Martin; J. Am. Chem. Soc. 1991, 113, pp. 7277-7287.
Proton-Transfer Chemistry of Urazoles and Related Imides, Amides, and Diacyl Hydrazides; Bausch, David, Dobrowolski, Guadalupe-Fasano, Gostowski, Selmarten, Prasad, Vaughn and Wang; J. Org. Chem. 1991, 56, pp. 5643-5651.
A General Synthesis of 4-Substituted 1,1-Dioxo-1,2,5-thiadiazolidin-3-ones Derived from a-Amino Acids; Muller and DuBois; J. Org. Chem. 1989, 54, pp. 4471-4473.
The Reaction of S-Methiodide Derivatives of Activated Thioureas with Hydroxylic Compounds. A Novel Synthesis of Mercaptans; Klayman, Shine, and Bower; J. Org. Chem., vol. 37, No. 10, 1972; pp. 1532-1537.
Efficient Solid-Phase Synthesis of Sulfahydantoins; Tremblay, Voyer, Boujabi and Dewynter; J. Comb. Chem. 2002, 4, pp. 429-435.
Identification of Novel Inhibitors of BCR-ABL Tyrosine Kinase via Virtual Screening: Peng, Huang, QI, Xie, Xu, Wang and Yang; Bioorganic & Medicinal Chemistry Letters 12 (2003) 3693-3699.
Implications of Protein Flexibility for Drug Discovery; Simon J. Teague; astrazeneca.com; REVIEWS.
The Conformational Plasticity of Protein Kinases; Huse and Kuriyan; Cell, vol 109, pp. 275-282; May 3, 2002.
Discovery of Novel Family of CDK Inhibitors with the Program LIDAEUS: Structural Basis for Ligand-Induced Disordering of the Activation Loop; Wu, McNae, Kontopidis, McClue, McInnes, Stewart, Wang, Zheleva, Marriage, Lane, Taylor, Fischer, and Walkinshaw; Structure, vol. 11, pp. 399-410; Apr. 2003.
Molecular Recognition with Convergent Functional Groups. 6. Synthetic and Structural Studies with a Model Receptor for Nucleic Acid Components; Askew, Ballester, Buhr, Jeong, Jones, Parris, Williams and Rebek, Jr.; J. Am. Chem. Soc. 1989, 111, pp. 1082-1090.
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate; Regan, Breitfelder, Cirillo, Gilmore, Graham, Hickey, Klaus, Madwed, Moriak, Moss, Pargellis, Pav, Proto, Swinamer, Tong, and Torcellini; J. Med. Chem. 2002, 45, pp. 2994-3008.
The Sequence of the Human Genome; J. Craig Venter, et al; Science Magazine; Feb. 16, 2001; vol. 291; pp. 1304-1351 (including Erratum/post date Jun. 8, 2001), 1 pg.
Initial sequencing and analysis of the human gen
Flynn Daniel L.
Petillo Peter A.
Deciphera Pharmaceuticals LLC
Grazier Nyeemah
Hovey & Williams, LLP
Saeed Kamal A.
LandOfFree
Anti-inflammatory medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3681935